CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Biogen CEO Michel Vounatsos: We Need To Be The 'Tesla' Of Drug Pricing Model | CNBC
Posted
January 8, 2018
Views
6,063
Likes
28
Comments
3
Engagement
January 8, 2018
6,063
28
3
0.51%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:41Now PlayingIn an exclusive CNBC interview Michel Vounatsos, Biogen CEO talks to CNBC's Meg Tirrell at the J.P. Morgan Health Care Conference about investing in health care under President Trump and the impact of tax reform on mergers and acquisition. Also Vounatsos weighs in on Biogen's drug pipeline and drug pricing.
» Subscribe to CNBC
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news
Find CNBC News on Facebook
Follow CNBC News on Twitter
Follow CNBC News on Google+
Follow CNBC News on Instagram
Biogen CEO Michel Vounatsos: We Need To Be The 'Tesla' Of Drug Pricing Model | CNBC
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
